Bottom line
What does LABU hold?
LABU held 163 positions as of Jul 31, 2026. Its largest holding is Dreyfus at 15.86% of the fund, and the top 10 positions add up to 64.8%. By asset type it is 26% do, 67% stocks, 36% cash & short-term funds.
Updated Sep 28, 2026
LABU top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | Dreyfus DREYFUS GOV'T CASH MGMT -INSTITUTIONAL CUSIP 262006208… |
Cash & short-term funds | 15.86% | $78.4M |
| 2 | Goldman Financial GOLDMAN FINL SQ TRSRY INST 506 |
Cash & short-term funds | 14.83% | $73.3M |
| 3 | N/a S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP |
DO | 9.63% | $47.6M |
| 4 | N/a S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP |
DO | 7.30% | $36.1M |
| 5 | Goldman Sachs Liq Es Fd A GOLDMAN SACHS FIN GOV 465 INSTITUT |
Cash & short-term funds | 5.35% | $26.5M |
| 6 | N/a S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP |
DO | 4.85% | $24.0M |
| 7 | N/a S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP |
DO | 3.87% | $19.2M |
| 8 | Apogee Therapeutics Inc APGE | Stocks | 1.11% | $5.5M |
| 9 | Oruka Therapeutics Inc ORKA | Stocks | 1.03% | $5.1M |
| 10 | Dianthus Therapeutics Inc DNTH | Stocks | 0.96% | $4.7M |
| 11 | Erasca Inc ERAS | Stocks | 0.93% | $4.6M |
| 12 | Twist Bioscience Corp TWST Twist Bioscience Corporation COM USD0.00001 |
Stocks | 0.92% | $4.6M |
| 13 | Kymera Therapeutics Inc KYMR Kymera Therapeutics Inc COM |
Stocks | 0.90% | $4.5M |
| 14 | Spyre Therapeutics Inc SYRE | Stocks | 0.89% | $4.4M |
| 15 | Revolution Medicines Inc RVMD Revolution Medicines Inc COM |
Stocks | 0.89% | $4.4M |
| 16 | Cg Oncology Inc CGON | Stocks | 0.88% | $4.4M |
| 17 | Protagonist Therapeutics Inc PTGX Protagonist Therapeutics Inc COM USD0.00001 |
Stocks | 0.88% | $4.4M |
| 18 | Praxis Precision Medicines Inc PRAX UW PRAXIS PRECISION MEDICINES I |
Stocks | 0.87% | $4.3M |
| 19 | Regeneron Pharmaceuticals Inc REGN Regeneron Pharmaceuticals, Inc. COM USD0.001 |
Stocks | 0.87% | $4.3M |
| 20 | Cogent Biosciences Inc COGT Cogent Biosciences Inc. COM |
Stocks | 0.85% | $4.2M |
| 21 | Natera Inc NTRA Natera Incorporation COM USD0.0001 |
Stocks | 0.84% | $4.2M |
| 22 | Arrowhead Pharmaceuticals Inc ARWR Arrowhead Pharmaceuticals Inc COM USD0.001 |
Stocks | 0.82% | $4.0M |
| 23 | Travere Therapeutics Inc TVTX Travere Therapeutics Inc COM |
Stocks | 0.82% | $4.0M |
| 24 | Roivant Sciences Ltd ROIV | Stocks | 0.81% | $4.0M |
| 25 | Relay Therapeutics Inc RLAY Relay Therapeutics Inc COM |
Stocks | 0.81% | $4.0M |
Source: SEC Form N-PORT, period ended Jul 31, 2026, filed Sep 28, 2026